| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HORIZON PHARMA PLC | 13,740,261 | 227,676,000 | 9.69% | ||
| 2 | MYLAN N V | 1,832,535 | 84,938,000 | 3.62% | ||
| 3 | NXSTAGE MED INC COM | 5,506,028 | 82,535,000 | 3.51% | ||
| 4 | HEALTHWAYS INC | 76,925,000 | 70,595,000 | 3.01% | PRN | |
| 5 | HORIZON PHARMA INVT LTD | 82,600,000 | 70,475,000 | 3.00% | PRN | |
| 6 | GLAXOSMITHKLINE PLC | 1,675,385 | 67,937,000 | 2.89% | ||
| 7 | AETNA INC NEW | 591,465 | 66,451,000 | 2.83% | ||
| 8 | PORTOLA PHARMACEUTICALS INC | 3,089,785 | 63,032,000 | 2.68% | ||
| 9 | AVEXIS INC COM | 2,236,701 | 60,928,000 | 2.59% | ||
| 10 | DAVITA INC | 822,000 | 60,318,000 | 2.57% | ||
| 11 | EDITAS MEDICINE INCORPORATED | 1,709,400 | 59,043,000 | 2.51% | ||
| 12 | Adeptus Health Inc | 956,533 | 53,126,000 | 2.26% | ||
| 13 | XENOPORT INC | 11,572,125 | 52,190,000 | 2.22% | ||
| 14 | VANDA PHARMACEUTICALS INC COM | 5,996,691 | 50,132,000 | 2.13% | ||
| 15 | GW PHARMACEUTICALS PLC | 674,373 | 48,656,000 | 2.07% | ||
| 16 | XENCOR INC COM | 3,467,512 | 46,534,000 | 1.98% | ||
| 17 | AAC HLDGS INC COM | 2,294,936 | 45,417,000 | 1.93% | ||
| 18 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 4,072,809 | 44,964,000 | 1.91% | ||
| 19 | WALGREENS BOOTS ALLIANCE INC | 511,457 | 43,085,000 | 1.83% | ||
| 20 | ENDOLOGIX INC | 40,000,000 | 38,632,000 | 1.64% | PRN | |
| 21 | UNIVERSAL AMERN CORP NEW | 5,285,500 | 37,738,000 | 1.61% | ||
| 22 | HEARTWARE INTL INC | 39,226,000 | 36,498,000 | 1.55% | PRN | |
| 23 | WRIGHT MED GROUP INC | 40,050,000 | 35,961,000 | 1.53% | PRN | |
| 24 | ARRAY BIOPHARMA INC 3 06/01/2020 | 45,000,000 | 35,876,000 | 1.53% | PRN | |
| 25 | SAGE THERAPEUTICS | 1,113,654 | 35,704,000 | 1.52% | ||
| 26 | AERIE PHARMACEUTICALS INC | 2,632,482 | 32,011,000 | 1.36% | ||
| 27 | EHEALTH INC COM | 3,264,588 | 30,654,000 | 1.31% | ||
| 28 | ZELTIQ AESTHETICS INCORPORATED | 1,104,417 | 29,996,000 | 1.28% | ||
| 29 | ENDOLOGIX INC | 40,941,000 | 29,871,000 | 1.27% | PRN | |
| 30 | ARRAY BIOPHARMA INC COM | 9,529,361 | 28,112,000 | 1.20% | ||
| 31 | FIVE PRIME THERAPEUTICS INC | 680,000 | 27,628,000 | 1.18% | ||
| 32 | MCKESSON CORP | 175,000 | 27,519,000 | 1.17% | ||
| 33 | Heartware International, Inc. | 870,634 | 27,355,000 | 1.16% | ||
| 34 | ACORDA THERAPEUTICS | 1,029,410 | 27,228,000 | 1.16% | ||
| 35 | DBV TECHNOLOGIES | 817,806 | 26,620,000 | 1.13% | ||
| 36 | RELYPSA INC | 1,873,471 | 25,386,000 | 1.08% | ||
| 37 | HEALTHWAYS INC | 2,475,387 | 24,977,000 | 1.06% | ||
| 38 | SPECTRANETICS CORP | 29,831,000 | 23,643,000 | 1.01% | PRN | |
| 39 | INFINITY PHARMACEUTICALS INC COM | 4,398,862 | 23,182,000 | 0.99% | ||
| 40 | KEMPHARM INC | 1,420,497 | 20,597,000 | 0.88% | ||
| 41 | ZAFGEN INC COM | 3,055,603 | 20,411,000 | 0.87% | ||
| 42 | ProNAi Therapeutics, Inc. | 3,001,302 | 20,229,000 | 0.86% | ||
| 43 | RITE AID CORP | 2,393,072 | 19,504,000 | 0.83% | ||
| 44 | GLOBAL BLOOD THERAPEUTICS IN COM | 1,193,811 | 18,934,000 | 0.81% | ||
| 45 | AXOGEN INC | 3,381,439 | 18,125,000 | 0.77% | ||
| 46 | AKARI THERAPEUTICS PLC | 1,150,700 | 16,110,000 | 0.69% | ||
| 47 | Nivalis Therapeutics Inc | 3,732,412 | 15,564,000 | 0.66% | ||
| 48 | FLUIDIGM CORP DEL | 27,715,000 | 15,353,000 | 0.65% | PRN | |
| 49 | ANTHEM INC | 102,000 | 14,177,000 | 0.60% | ||
| 50 | GALAPAGOS NV | 327,626 | 13,701,000 | 0.58% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-065661, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
